Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 37484960 | PubTator, text mining | PubMed |
| HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5. | Pharmacol Res | 2023 | 37480971 | PubTator, text mining | PubMed |
| METTL3 promotes hyperoxia-induced pyroptosis in neonatal bronchopulmonary dysplasia by inhibiting ATG8-mediated autophagy. | Clinics (Sao Paulo) | 2023 | 37478627 | PubTator, text mining | PubMed |
| TMEM41A overexpression correlates with poor prognosis and immune alterations in patients with endometrial carcinoma. | PLoS One | 2023 | 37478120 | PubTator, text mining | PubMed |
| RNautophagic regulation of DNMT3a-dependent DNA methylation by Linc00942 enhances chemoresistance in gastric cancer. | Clin Transl Med | 2023 | 37477089 | PubTator, text mining | PubMed |
| Crosstalk between RNA m6A and DNA methylation regulates transposable element chromatin activation and cell fate in human pluripotent stem cells. | Nat Genet | 2023 | 37474847 | PubTator, text mining | PubMed |
| The disordered C terminus of ALKBH5 promotes phase separation and paraspeckles assembly. | J Biol Chem | 2023 | 37474102 | Swiss-Prot, curated | PubMed |
| Poly(GR) interacts with key stress granule factors promoting its assembly into cytoplasmic inclusions. | Cell Rep | 2023 | 37471224 | PubTator, text mining | PubMed |
| Building an Immune-Related Genes Model to Predict Treatment, Extracellular Matrix, and Prognosis of Head and Neck Squamous Cell Carcinoma. | Mediators Inflamm | 2023 | 37469759 | PubTator, text mining | PubMed |
| circRNF13, a novel N6-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability. | Cell Death Discov | 2023 | 37468464 | PubTator, text mining | PubMed |
| Establishment of a prognostic model based on m6A regulatory factors and stemness of hepatocellular carcinoma using RNA-seq data and scRNA-seq data. | J Cancer Res Clin Oncol | 2023 | 37466793 | PubTator, text mining | PubMed |
| Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m6 A RNA methylation in ocular melanoma. | Cancer Commun (Lond) | 2023 | 37466203 | PubTator, text mining | PubMed |
| Spotlights on extracellular vesicles in hepatocellular carcinoma diagnosis and treatment: an update review. | Front Bioeng Biotechnol | 2023 | 37456728 | PubTator, text mining | PubMed |
| Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival. | J Biol Chem | 2023 | 37454738 | Swiss-Prot, curated | PubMed |
| ALKBH5-mediated m6A demethylation fuels cutaneous wound re-epithelialization by enhancing PELI2 mRNA stability. | Inflamm Regen | 2023 | 37452367 | PubTator, text mining | PubMed |
| METTL14 mediates m6a modification on osteogenic proliferation and differentiation of bone marrow mesenchymal stem cells by regulating the processing of pri-miR-873. | Mol Med Rep | 2023 | 37449516 | PubTator, text mining | PubMed |
| Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review). | Oncol Rep | 2023 | 37449515 | PubTator, text mining | PubMed |
| Regulation and Functions of α6-Integrin (CD49f) in Cancer Biology. | Cancers (Basel) | 2023 | 37444576 | PubTator, text mining | PubMed |
| Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance. | Cancers (Basel) | 2023 | 37444568 | PubTator, text mining | PubMed |
| The Regulation of m6A Modification in Glioblastoma: Functional Mechanisms and Therapeutic Approaches. | Cancers (Basel) | 2023 | 37444417 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=48